START | San Antonio

Futó vizsgálatok

• Toboroz

  JUR-003 in Adult Patients With Metastatic Prostate Cancer

  NCT07824349· 1. fázis· Forrás

• Még nem toboroz

  Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

  NCT07707674· 1. fázis· Forrás

• Toboroz

  DBC-664 in Adult Patients With Solid Tumors

  NCT07705035· 1. fázis· Forrás

• Toboroz

  Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

  NCT07652242· 1. fázis· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· 2. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

  NCT07542704· 1. fázis· Forrás

• Toboroz

  Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

  NCT07558733· 1/2. fázis· Forrás

• Toboroz

  A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

  NCT07535112· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· 2. fázis· Forrás

• Toboroz

  A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

  NCT07195682· 1. fázis· Forrás

• Toboroz

  Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  NCT07349537· 1. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  NCT07318805· 1. fázis· Forrás

• Toboroz

  Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  NCT07444814· 1. fázis· Forrás

• Toboroz

  A Study of ZW251 in Participants With Advanced Solid Tumors

  NCT07164313· 1. fázis· Forrás

• Toboroz

  Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  NCT07145255· 1/2. fázis· Forrás

• Toboroz

  Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  NCT07030257· 1/2. fázis· Forrás

• Toboroz

  A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  NCT06730347· 2. fázis· Forrás

• Toboroz

  Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

  NCT07080242· 1. fázis· Forrás

• Toboroz

  A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  NCT06880549· 1. fázis· Forrás

• Toboroz

  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  NCT06914128· 1/2. fázis· Forrás

• Toboroz

  Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

  NCT06784193· 1. fázis· Forrás

• Toboroz

  ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

  NCT06597721· 1. fázis· Forrás

• Toboroz

  Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  NCT06582017· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

  NCT06206837· 1/2. fázis· Forrás

• Toboroz

  A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  NCT06234423· 1. fázis· Forrás

• Toboroz

  Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  NCT06293898· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  NCT06004245· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of ADRX-0706 in Select Advanced Solid Tumors

  NCT06036121· 1. fázis· Forrás

• Toboroz

  Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  NCT05985655· 1/2. fázis· Forrás

• Toboroz

  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  NCT05786924· 1/2. fázis· Forrás

• Toboroz

  First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  NCT05768139· 1/2. fázis· Forrás

• Fut, nem toboroz

  Study of CHS-114 in Participants With Advanced Solid Tumors

  NCT05635643· 1. fázis· Forrás

• Fut, nem toboroz

  A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

  NCT05614102· 1. fázis· Forrás

• Fut, nem toboroz

  A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

  NCT05537740· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

  NCT05355701· 1. fázis· Forrás

• Fut, nem toboroz

  CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

  NCT05251714· 1/2. fázis· Forrás

• Fut, nem toboroz

  First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

  NCT05156866· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák14 toboroz
• Hasnyálmirigyrák8 toboroz
• Petefészekrák8 toboroz
• Vastagbélrák8 toboroz
• Prosztatarák5 toboroz
• Áttétes emlőrák4 toboroz
• Hólyagrák4 toboroz
• Méhtestrák4 toboroz
• Fej-nyaki daganatok3 toboroz
• Máj- és epeúti rák3 toboroz
• Tripla negatív emlőrák3 toboroz
• Vesedaganat3 toboroz
• Méhnyakrák2 toboroz
• Mielóma multiplex2 toboroz
• Glioblasztóma1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Melanóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

  NCT06546553· 1. fázis· Forrás

• Lezárult

  A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

  NCT05858164· 1. fázis· Forrás